Indivior Pharmaceuticals INDV
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 35.88 | 93.10 | 26.81 | 0.79 | 81,000 | 102 |
| 2025Q3 | 24.11 | 87.76 | 23.50 | 0.33 | 43,000 | 43 |
| 2025Q2 | 14.74 | 92.31 | 612.98 | 0.14 | 72,000 | 18 |
| 2025Q1 | 9.53 | 94.29 | 396.78 | 0.38 | 66,000 | 47 |
| 2024Q4 | 12.43 | 94.74 | 0.07 | 292,000 | 59 | |
| 2024Q3 | 9.75 | 106.81 | 0.03 | 73,000 | 22 | |
| 2024Q2 | 16.12 | 115.39 | -0.79 | 42,000 | -97 | |
| 2024Q1 | 21.42 | 1456.68 | 0.45 | 74,000 | 61 | |
| 2023Q4 | 15.27 | 0.38 | 57,000 | 54 | ||
| 2023Q3 | 23.07 | -0.98 | -183,000 | -135 | ||
| 2023Q2 | 23.80 | 0.27 | 61,000 | 39 | ||
| 2023Q1 | 83.82 | 0.31 | 57,000 | 44 | ||
| 2022Q4 | -1.34 | -261,000 | -183 | |||
| 2022Q3 | 0.28 | 56,000 | 41 | |||
| 2022Q2 | 0.33 | 60,000 | 48 | |||
| 2022Q1 | 0.28 | 54,000 | 41 | |||
| 2020Q4 | 106.12 | -156,000 | -148 |